Ada Expands Global Leadership Team to Help Drive Rapid Company Growth

– Ada makes three appointments to the management team, hiring Gülsah Wilke and Torsten Schero respectively as Chief Operating Officer and Chief Financial Officer, and appointing Vanessa Lemarié as Chief Client Officer

– The new appointments bring extensive experience in scaling technology companies and driving operational excellence in high growth and incumbent companies

BERLIN and LONDON, July 15, 2021 / PRNewswire / – Ada, the global healthcare company, today announces the appointment of digital transformation veterans Gülsah Wilke, Torsten Schero and Vanessa Lemarié respectively as Chief Operating Officer, Chief Financial Officer and Chief Client Officer. Wilke, Schero and Lemarié will be at the heart of Ada’s ambitious business growth trajectory in their new roles, as the company accelerates its path to becoming the world’s first personalized operating system for healthcare.

Torsten Schero, Gülsah Wilke, Vanessa Lemarié (PRNewsfoto / Ada Health)

The appointments follow a period of significant growth for Ada: its AI-powered health assessment and care navigation platform is the most popular and highest-rated symptom assessment app worldwide, with more than 23 million reviews completed since its launch. Meanwhile, the company also quickly launched a suite of AI-powered business solutions, collaborating with a range of healthcare systems, insurers, life science companies and global organizations to nonprofit to integrate its symptom assessment and care navigation solutions into a wide variety of digital care pathways. Earlier this year, the company announced a $ 90 million Series B investment led by Leaps by Bayer to further accelerate this growth. Wilke, Schero and Lemarié join Ada’s management team alongside co-founder and CEO Daniel Nathrath, co-founder and chief physician Dr. Claire Novorol, and CTO Dr. Urban Liebel.

Daniel Nathrath, CEO and co-founder of Ada, said:

“We couldn’t be happier to welcome Gülsah and Torsten to Ada, and welcome Vanessa to the leadership team, as we enter an extremely exciting new chapter for the company. Our goal at Ada is to improve healthcare outcomes for over 1 billion people worldwide, an ambition that we can only achieve with the best people on board; Gülsah and Torsten both have exceptional backgrounds in leading edge strategy and organizational excellence in high growth companies, and bring with them a wealth of operational skills and financial expertise. Vanessa has played an absolutely critical role in Ada’s continued success and business development strategy, and we are delighted that she continues to drive the growth of the company in her new role. These appointments put us in an excellent position to continue our ambitious growth journey, expand our consumer and business offerings, and transform the way people access healthcare for the better. “

Gülsah Wilke: Chief Operating Officer

Gülsah Wilke is a technology leader, advisor and investor who brings extensive experience in scaling technology companies, building organizational excellence and driving digital transformation. Most recently, Wilke was an investor and head of operations, pricing and portfolio at Axel Springer. As a member of the Supervisory Board of StepStone, she was instrumental in the success of Axel Springer’s largest portfolio company as well as in the merger of Axel Springer with KKR. Previously, she led Axel Springer’s Silicon Valley office, identified partnership and investment opportunities, and built a transatlantic digital hub. Prior to that, Wilke worked as a management consultant at McKinsey & Company and IBM, advising international companies on strategic and digital transformation. She is passionate about promoting diverse teams and building leadership in the field of technology, and uses her experience, expertise and network as a co-founder of the 2Hearts Tech community (supported by Deutschlandstiftung Integration) to empower talents from immigrant backgrounds in the technological ecosystem.

As part of his role as COO, Wilke will oversee Ada’s strategic process and lead operations, legal services, marketing and communications as well as people and culture.

Gülsah Wilke, COO at Ada, said:

“Having observed the market for a number of years, I have been very impressed with Ada’s superior technology and knowledge base, cutting-edge AI and goal-oriented culture to deliver to the people of the world entire access to health care. I am delighted to be joining the Ada team and look forward to continuing to shape the already extraordinary success and growth of the company alongside the team. “

Torsten Schero: Financial director

Torsten Schero is a visionary and strategic thinker with over 15 years of experience in CFO and CEO roles in start-up, large-scale and incumbent companies. He brings extensive experience driving operational excellence, building effective teams and managing financial and operational services in high growth companies. Prior to Ada, Schero spent several years at Amazon Deutschland as CFO and Managing Director of Media Operations for the DACH region, was CEO of Rebuy Recommerce and Getnow, and held several other management and advisory positions.

In his new role as Chief Financial Officer, Schero will oversee Ada’s financial strategy and continued development as the company charts new international growth as well as investor relationship management.

Torsten Schero, Chief Financial Officer at Ada, said:

“It is extremely exciting to join Ada at such a crucial time in its growth journey, and to play a key role in driving the company’s financial strategy and key investor relations through this new chapter. As the healthcare market increasingly turns to digital services. , there is a huge opportunity for Ada and its superior AI technology. I am a firm believer in the right of people to have access to health systems and medical knowledge, and I am happy to work with such a great team to make this vision a reality for more people around the world. “

Vanessa Lemarié: Customer Director

Vanessa Lemarié previously led the company’s life sciences partnerships as Ada’s senior vice president of life sciences and rare diseases, working with a growing number of pharmaceutical and consumer health companies to implement Ada’s technology and enable access to high-quality medical health assessments and care navigation solutions, as well as as a leader of the Rare Disease Initiative of Ada. Prior to Ada, Lemarié spent over fifteen years working with Bayer Pharmaceuticals, holding various global and regional leadership roles in pharmaceutical business operations.

In his new role as Chief Client Officer, Vanessa Lemarié oversee Ada’s business development, business strategy and partnerships across all industries and healthcare sectors.

Vanessa Lemarié, Chief Client Officer at Ada, said:

“It has been an absolute privilege to lead our life sciences collaborations over the past two years, working with our amazing teams to make Ada the best user health assessment solution that also generates value for many customers in the healthcare field.

Striving to always deliver the best possible engagements with our customers, entering into ambitious partnerships and learning how we best help users around the world manage their health will be key to our continued growth and business success. I am delighted to now lead our sales teams and further develop the exceptional customer activity of Ada. “

About Ada

Ada is a global healthcare company founded by physicians, scientists and industry pioneers to create new possibilities for personal health and turn knowledge into better results. Its core system connects medical knowledge with smart technology to help all people actively manage their health and healthcare professionals deliver effective care, and the company works with leading healthcare providers, organizations and governments to achieve this vision. The Ada platform has 11 million users worldwide and has completed 23 million reviews since its global launch in 2016.

In May 2021, Ada raised $ 90 million in a Series B investment round led by Leaps by Bayer, the impact investing arm of Bayer AG, with participation from Samsung Catalyst Fund, Vitruvian Partners, Inteligo Bank, F4 and Mutschler Ventures.

To learn more, visit www.ada.com.

Contact:

[email protected]